Diabetic Foot Ulcer Treatment Market Trends

  • Report ID: 4603
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Diabetic Foot Ulcer Treatment Market Trends

Growth Drivers

  • An Increase In Sedentary Lifestyles- According to the Centers For Disease Control And Prevention, approximately 60% of U.S. adults fail to engage in an adequate amount of physical activity. Nearly 25 percent of American adults are completely sedentary. An increasing number of diabetics are being diagnosed as a result of physical inactivity. In times of rapid modernization, the food habits of the people have been adversely affected, which in turn has been combined with a faulty and inactive lifestyle. Ultimately, this results in the onset of diabetes and leads to the formation of diabetic foot ulcers as a result. This factor is anticipated to drive global diabetic foot ulcer treatment market growth over the forecast period.

  • Rise in The Geriatric Population Around The World- The group of elderly are particularly affected by diabetes, as their immunity lowers due to old age, they become the prime age group to be burdened with diabetic foot ulcers.  According to a recent report published by the World Bank, at the end of 2021, there were a total of 747,238,580 people over 60 years of age living around the world, and the number of elderly people is anticipated to rise in the future.

  • Rapidly Growing Number of People Developing Diabetic Foot Ulcers (DFU)- It is estimated that between 9 and 26 million people worldwide suffer from diabetic foot ulcers every year. A diabetic foot ulcer is likely to develop during the lifetime of 16 to 24% of patients with diabetes complications.

  • Increasing Prevalence of Obesity Worldwide- Obesity is one the primary risk factors of diabetic ulcers, obesity defects the tissues that causes insulin resistance and glucose uptake. In the period 2000-2020, obesity prevalence increased by 30.5% to 41.9% in the United States. Ages 20-39 showed an obesity prevalence of 39.8%, 40-59 age groups, 44.3%, and 60+ age groups showed a prevalence of 41.5%.

  • Surge In Number Of People Suffering From Type 2 Diabetes - It is expected that the worldwide prevalence of type 2 diabetes will increase to 70,000 per 100,000 individuals by 2030, reflecting an increase in prevalence across all regions of the world.

Challenges

  • High Cost Associated With Advanced Diabetic Foot Ulcer Treatment-despite of the high prevalence of diabetic patients and diabetic foot ulcers, there are no adequate reimbursement policies for its treatment. Moreover, the devices used for advanced wound care are also expensive, which makes the allover treatment costly.
  • Patient Management Rules and Regulations
  • Unawareness of the Availability of Treatment For Diabetic Foot Ulcers

Diabetic Foot Ulcer Treatment Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

6.3%

Base Year Market Size (2024)

USD 2.26 billion

Forecast Year Market Size (2037)

USD 4.93 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4603
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of diabetic foot ulcer treatment is evaluated at USD 2.37 billion.

The diabetic foot ulcer treatment market size was valued at USD 2.26 billion in 2024 and is likely to exceed USD 4.93 billion by the end of 2037, registering over 6.3% CAGR during the forecast period i.e., between 2025-2037. An increase in sedentary lifestyles, surge in number of people suffering from type 2 diabetes along with increasing obesity among people will boost the market growth.

North America is projected to hold largest industry share by 2037, attributed to ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer.

The major players in the market include UPM, Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Hill-Rom Holdings, Inc., ConvaTec Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample